OPPORTUNISTIC INFECTION PROTOCOLS
Past & Present Performance: HIV/AIDS and non-HIV Multicenter Clinical Trials (3/87 - 4/98)
conducted by the Tulane-LSU AIDS Clinical Trials Collaborative Programs

 
PCP
n=
Cryptococcal
Meningitis
n=
Toxoplasmic
Encephalitis
n=
Fungal
Prophylaxis
n=
Disseminated
Histoplasmosis
n=
Tuberculosis
n=
ACTG 021
10
 ACTG 026
3
 ACTG 77/977
2
 ACTG 981
17
 ACTG 084
1
 DATRI 008
1
ACTG 039
4
 ACTG 059
10
 CPCRA 010
25
 ACTG 120
2
 ACTG 309
1
ACTG 040
9
 ACTG 125
8
 ACTG 174
1
ACTG 081
32
 ACTG 159
5
 MSG #36
4
ACTG 108
24
 MSG 17
4
CPCRA 005
58
Total Enrolled
137
30
2
42
8
2

 
 
CMV
n=
Disseminated
MAC
n=
Natural
History
n=
Wasting
Syndrome
n=
Oral
Candidiasis
n=
Herpes
Simplex*
 n=
ACTG 129
8
 ACTG 135
3
 ACTG 181
16
 DATRI 004
7
 SCH 084
20
 BW 07
17
CPCRA 023
15
 ACTG 362
3
 ITR-USA-8
6
 BW 08
6
ACTG 360
3
  
Total Enrolled
26
6
16
7
26
23

 
 
Invasive
Aspergillosis
n=
Candidemia
(Non-neutropenic Pts.)
n=
Persistent Fever/
Neutropenia
n=
Invasive Fungal
Infections
n=
Pfizer 150-602
0
 Pfizer R-0437
0
 Pfizer 150-603
0
 Pfizer 150-604
0
MSG #34
75
0
Total Enrolled
0
75
0
0

* LSU HIV Outpatient Program only